PLD3: In vitro functional characterization and autophagy pathway-mediated regulatory effects in gastric cancer

Yu Li1, Jinrui Geng1, Na Liu1

  • 1First Clinical Medical College, Gansu University of Chinese Medicine, Lanzhou, 730000, China.

Abstract

Insights

Phospholipase D family member 3 (PLD3) is overexpressed in gastric cancer, correlating with poor survival. Inhibiting autophagy in PLD3-overexpressing cells reduces proliferation and promotes apoptosis, suggesting PLD3 as a prognostic biomarker.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Phospholipase D family member 3 (PLD3) is a transmembrane glycoprotein involved in cellular processes like nucleic acid turnover and immune signaling.
  • While PLD3's general functions are known, its specific role in gastric cancer development remains unclear.

Purpose of the Study:

  • To investigate the expression, prognostic value, and functional role of PLD3 in gastric cancer.
  • To explore the mechanistic link between PLD3 and autophagy in gastric tumorigenesis.

Main Methods:

  • Analysis of The Cancer Genome Atlas (TCGA) datasets for PLD3 expression and correlation with clinical outcomes.
  • Validation of PLD3 expression in gastric cancer tissues and cell lines using RT-qPCR.
  • In vitro functional assays to assess the impact of PLD3 modulation on cancer cell behavior and autophagy.

Main Results:

  • PLD3 is significantly overexpressed in gastric carcinoma tissues, with higher expression linked to reduced overall patient survival.
  • Knockdown of PLD3 suppressed malignant phenotypes, while PLD3 overexpression enhanced malignancy and inhibited apoptosis.
  • Inhibition of autophagy using Vps34-IN-1 reversed PLD3-driven proliferation and promoted apoptosis in gastric cancer cells.

Conclusions:

  • PLD3 is significantly upregulated in gastric cancer and serves as a promising prognostic biomarker.
  • PLD3 influences gastric cancer progression, potentially through its interaction with autophagy pathways.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
6.0K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
10.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.5K